Strategic Transactions Counsel Moderates Panel at Life Sciences IP Due Diligence Conference

October 1, 2019

Strategic transactions counsel Ryan Murphey (New York) will moderate a panel on “New Developments in the Courts and Congress Influencing IP Due Diligence” at the American Conference Institute’s Third Annual Summit on Life Sciences IP Due Diligence on November 15 in Boston.

The panel will address insights into how recent court decisions and pending legislation relating to patent rights will impact life sciences pipelines and reshape future business analyses. Discussion points will include pending patent reform legislation and adapting due diligence analysis, and understanding Section 101 guidance and related considerations in patent applications.

Panel participants include Dana-Farber Cancer Institute intellectual property counsel Hilary Libka, Akebia Therapeutics vice president and chief IP counsel Henry Gu, Gibson Dunn partner Jane Love and Finnegan and Henderson partner Tom Irving.